Core Insights - Procter & Gamble (PG) is focusing on innovation in Beauty and Personal Care as a key growth strategy, emphasizing faster innovation cycles and premiumization across brands like Olay, SK-II, Pantene, and Head & Shoulders [1][10] - The company is experiencing stronger organic sales growth in premium skin care lines compared to mass alternatives, driven by sustained demand in international markets, particularly Greater China [2] - The Personal Care segment is benefiting from productivity-driven innovation, with improvements in performance and convenience supporting pricing and mix, despite uneven volume growth in a value-conscious consumer environment [3] Innovation and Market Position - Innovation is helping PG offset macro pressures such as input cost inflation and private-label competition, positioning the company for sustainable, margin-accretive growth [4] - Continued innovation in Beauty and Personal Care is central to PG's strategy, reinforcing brand equity and supporting long-term growth despite a challenging global consumer backdrop [5] Financial Performance - PG's shares have gained 3.2% in the past six months, contrasting with a 2.2% drop in the industry [9] - The company trades at a forward price-to-earnings ratio of 21.68X, higher than the industry average of 19.04X [11] - The Zacks Consensus Estimate for PG's fiscal 2026 and fiscal 2027 EPS reflects year-over-year growth of 2.2% and 4.5%, respectively, although estimates have been revised downward in the past 30 days [13]

OAKLAND, Calif., Feb. 3, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today reported results for the second quarter of fiscal year 2026, which ended December 31, 2025. Second-Quarter Fiscal Year 2026 Summary Following is a summary of key results for the second quarter. All comparisons are with the second quarter of fiscal year 2025 unless otherwise stated. 1 "Our secondquarter results were generally in line with our expectations and reflect continued progress against our strategic priorities. These r ...